SG11202109119QA - Systems and methods for the treatment of symptoms associated with migraines - Google Patents

Systems and methods for the treatment of symptoms associated with migraines

Info

Publication number
SG11202109119QA
SG11202109119QA SG11202109119QA SG11202109119QA SG11202109119QA SG 11202109119Q A SG11202109119Q A SG 11202109119QA SG 11202109119Q A SG11202109119Q A SG 11202109119QA SG 11202109119Q A SG11202109119Q A SG 11202109119QA SG 11202109119Q A SG11202109119Q A SG 11202109119QA
Authority
SG
Singapore
Prior art keywords
migraines
systems
treatment
methods
symptoms associated
Prior art date
Application number
SG11202109119QA
Inventor
Marguerite Manteau-Rao
Antoun Nabhan
Original Assignee
Pear Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pear Therapeutics Inc filed Critical Pear Therapeutics Inc
Publication of SG11202109119QA publication Critical patent/SG11202109119QA/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024—Detecting, measuring or recording pulse rate or heart rate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1118—Determining activity level
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0219—Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
SG11202109119QA 2019-02-22 2020-02-21 Systems and methods for the treatment of symptoms associated with migraines SG11202109119QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962809251P 2019-02-22 2019-02-22
PCT/US2020/019202 WO2020172520A1 (en) 2019-02-22 2020-02-21 Systems and methods for the treatment of symptoms associated with migraines

Publications (1)

Publication Number Publication Date
SG11202109119QA true SG11202109119QA (en) 2021-09-29

Family

ID=72141449

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109119QA SG11202109119QA (en) 2019-02-22 2020-02-21 Systems and methods for the treatment of symptoms associated with migraines

Country Status (11)

Country Link
US (1) US11793472B2 (en)
EP (1) EP3928328A4 (en)
JP (1) JP2022521020A (en)
KR (1) KR20210138590A (en)
CN (1) CN113924627A (en)
AU (2) AU2020225481A1 (en)
CA (1) CA3130620A1 (en)
IL (1) IL285627A (en)
NZ (1) NZ780195A (en)
SG (1) SG11202109119QA (en)
WO (1) WO2020172520A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024024316A1 (en) * 2022-07-25 2024-02-01 テルモ株式会社 Computer program, information processing device, information processing method, and training model generation method
WO2024024317A1 (en) * 2022-07-25 2024-02-01 テルモ株式会社 Computer program, information processing device, information processing method, and learning model generation method
WO2024024315A1 (en) * 2022-07-25 2024-02-01 テルモ株式会社 Computer program, information processing device, information processing method, and learning model generation method
WO2024024314A1 (en) * 2022-07-25 2024-02-01 テルモ株式会社 Computer program, pain management assistance device, and pain management assistance method

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284794B1 (en) * 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
EP1399160A4 (en) * 2001-06-12 2004-08-25 Merck & Co Inc Nr2b receptor antagonists for the treatment or prevention of migraines
WO2003063684A2 (en) * 2002-01-25 2003-08-07 Intellipatch, Inc. Evaluation of a patient and prediction of chronic symptoms
US7941200B2 (en) * 2005-12-08 2011-05-10 Roche Diagnostics Operations, Inc. System and method for determining drug administration information
JP2008237718A (en) * 2007-03-28 2008-10-09 Quality Kk Device and program for compounding output
JP2010008825A (en) 2008-06-30 2010-01-14 Nikon Corp Observation optical system
NZ622157A (en) 2008-12-30 2015-10-30 Teva Pharmaceuticals Int Gmbh Electronic control of drug delivery system
US20140052465A1 (en) * 2012-08-16 2014-02-20 Ginger.io, Inc. Method for modeling behavior and health changes
US10665349B2 (en) 2014-09-05 2020-05-26 University Of Cincinnati Methods for determining risk and treating diseases and conditions that correlate to weather data
EP3226972A4 (en) 2014-12-01 2018-08-08 Achelios Therapeutics, Inc. Methods and compositions for treating migraine and conditions associated with pain
EP3838138A3 (en) * 2015-08-26 2021-09-15 ResMed Sensor Technologies Limited Systems and methods for monitoring and management of chronic disease
US10473955B2 (en) 2015-11-13 2019-11-12 SensorRx, Inc. Automated digital migraine diary
ES2634874B2 (en) 2016-02-29 2018-03-16 Fundación Para La Investigación Biomédica Del Hospital Universitario La Princesa Method to determine the level of activation of the trigeminal vascular system
WO2018037080A1 (en) * 2016-08-25 2018-03-01 Novo Nordisk A/S Starter kit for basal insulin titration
JP6533243B2 (en) * 2017-03-01 2019-06-19 ヤフー株式会社 Provision apparatus, provision method, and provision program

Also Published As

Publication number Publication date
JP2022521020A (en) 2022-04-04
NZ780195A (en) 2024-03-22
US20200268324A1 (en) 2020-08-27
WO2020172520A1 (en) 2020-08-27
EP3928328A1 (en) 2021-12-29
EP3928328A4 (en) 2022-11-02
AU2020225481A1 (en) 2021-10-14
US11793472B2 (en) 2023-10-24
CA3130620A1 (en) 2020-08-27
IL285627A (en) 2021-09-30
AU2023229478A1 (en) 2023-09-28
CN113924627A (en) 2022-01-11
KR20210138590A (en) 2021-11-19

Similar Documents

Publication Publication Date Title
IL289650A (en) Azolopyrimidine for the treatment of cancer-related disorders
IL277234A (en) Systems and methods for the treatment of hemoglobinopathies
IL268211A (en) Cannabinoid-containing complex mixtures for the treatment of mast cell-associated or basophil-mediated inflammatory disorders
IL285627A (en) Systems and methods for the treatment of symptoms associated with migraines
EP3672500A4 (en) Devices, systems, and methods for the treatment of vascular defects
IL271117B (en) Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
IL265315A (en) Methods and systems for adaptive treatment of disorders in the gastrointestinal tract
SG11202104501UA (en) Systems and methods for the treatment of eye conditions
EP3478287A4 (en) Treatment of sepsis and related inflammatory conditions by local neuromodulation of the autonomic nervous system
EP3538050A4 (en) Devices and methods for reducing the symptoms of maladies of the vestibular system
SG11202009864UA (en) Gas treatment system and ship including same
EP3294171A4 (en) Systems and methods for treating the bladder with condensable vapor
IL283948A (en) Methods for the treatment of depression
SG10202012106WA (en) Methods for treating inflammatory conditions of the lungs
IL282007A (en) Medicament for the treatment of chronic cough
GB2554354B (en) Systems for adaptive treatment of disorders in the gastrointestinal tract
EP4171469C0 (en) Systems for associating symptoms with medical conditions
IL290217A (en) Contacting system and use of the contacting system
HUE056213T2 (en) Treatment system
IL259674B (en) Benzofuran derivatives for the treatment of cns and other disorders
IL283031A (en) Vibegron for the treatment of overactive bladder symptoms
EP4084668A4 (en) Vapor therapy systems and methods
IL266726A (en) Therapies for the treatment of lidocaine-ineffective and hypokalemic conditions
EP3762915C0 (en) Technical conversion of firearms for the implementation of mr and ar interaction
EP3720351A4 (en) Methods and systems for the treatment of sleep apnea